Quick Context: CAPT Connie Jung, Senior Advisor for Policy in the Office of Drug Security, Integrity, and Response (ODSIR), reviews advances in ... FDA experts: *Review the new BsUFA III commitments, focusing on supplement categories and associated timelines, guidance ...
Redi Industry Fellowship Program Information Session -
CAPT Connie Jung, Senior Advisor for Policy in the Office of Drug Security, Integrity, and Response (ODSIR), reviews advances in ... FDA experts: *Review the new BsUFA III commitments, focusing on supplement categories and associated timelines, guidance ... Kevin Bugin, Deputy Director for Operations for the Office of New Drugs (OND) provides a background and overview of the ...
Important details found
- CAPT Connie Jung, Senior Advisor for Policy in the Office of Drug Security, Integrity, and Response (ODSIR), reviews advances in ...
- FDA experts: *Review the new BsUFA III commitments, focusing on supplement categories and associated timelines, guidance ...
- Kevin Bugin, Deputy Director for Operations for the Office of New Drugs (OND) provides a background and overview of the ...
- Tamy Kim, PharmD, Director for Regulatory Affairs and Policy in the Oncology Center of Excellence (OCE) describes OCE's ...
- Califf, MD, Commissioner of Food and Drugs at FDA, delivers the keynote address to the 2022 Regulatory Education for ...
Why this topic is useful
This topic is useful when readers need a quick overview first, then want to move into supporting details and related references.
Frequently Asked Questions
Why are related topics included?
Related topics help readers compare nearby references and understand the broader subject.
What is this page about?
This page summarizes Redi Industry Fellowship Program Information Session and connects it with related entries, references, and supporting context.
Is the information always complete?
Not always. Some topics may need verification from official or primary sources.
